This is a $55,877.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 360 mg Deferasirox tablets, a medication used to treat chronic iron overload. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award is a delivery order valued at $14,039.18 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for the delivery of 360 mg Deferasirox tablets, a medication used to treat iron overload. The contract is a firm fixed price award and does not include any set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,415.26 contract is for the provision of the medication Deferasirox 500 mg tablets for suspension, with a completion date of February 15, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a...
The federal contract award is for the delivery of Deferasirox 360 mg tablets in a 30-count package. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $71,118.73 and is a delivery order with a firm fixed price. The ultimate completion date for the contract is December 5, 2024. There is no set-aside designation for this contract....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEFERASIROX 180 MG GRANULE PKT 30S, with a ceiling value of $1,728.00 and a performance period through May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Deferasirox 500 mg tablets for suspension. The contract has a ceiling value of $2,455.30 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which is issued under a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,006.27 firm fixed-price contract is for the delivery of Deferiprone 500 mg tablets, a medication used to treat iron overload. The contract is not set aside and represents an order under AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $34,922.95, is for the supply of 4,565,781,570 units of the pharmaceutical product Deferasirox 360 mg Tablet. The contract has an ultimate completion date of September 13, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,146,414 units of 500 mg deferiprone tablets, valued at $4,006.27. The contract has an ultimate completion date of January 30, 2025 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp in the amount of $25,052.94 for the supply of Deferiprone 1,000 mg tablets. The contract has a firm fixed price and provides for the delivery of this pharmaceutical product through June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, supports the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other government...